Topline Capital Management, LLC, Topline Capital Partners, LP, and Collin McBirney filed a Schedule 13G Amendment No. 2 with the SEC on November 16, 2026, disclosing that as of September 30, 2026, they hold no beneficial ownership in Nutex Health Inc. common stock.
Key Highlights
- Zero beneficial ownership: All three reporting persons - Topline Capital Management, LLC; Topline Capital Partners, LP; and Collin McBirney - each report 0.00 shares beneficially owned.
- 0% of class: The percent of class represented by the aggregate amount beneficially owned is reported as 0% for each reporting person.
- Triggering event date: The date of the event requiring this filing is stated as September 30, 2026.
- Confirmed exit as of November 13, 2026: According to the filing, "as of November 13, 2026, the Fund does not beneficially own shares of the issuer's common stock."
- Issuer: Nutex Health Inc., with common stock carrying a $0.001 par value and CUSIP number 07079U306.
- Beneficial ownership disclaimed: The filing states that each of TCM and Mr. McBirney "expressly disclaims beneficial ownership as to the Securities held by the Fund, except to the extent of its or his pecuniary interests therein."
Topline Capital and Collin McBirney Report Full Exit from Nutex Health Position
Topline Capital Management, LLC (TCM), a California-organized investment adviser, Topline Capital Partners, LP (the Fund), a Delaware limited partnership, and Collin McBirney, identified as the member-manager of TCM, jointly filed Amendment No. 2 to Schedule 13G covering Nutex Health Inc. (NASDAQ:NUTX) common stock. The filing was submitted on November 16, 2026, and discloses that the reporting persons no longer hold any beneficial ownership in the issuer's shares.
According to the filing, all voting and dispositive power figures - sole and shared - are reported as zero for each of the three reporting persons. Item 4 of the filing states that "as of November 13, 2026, the Fund does not beneficially own shares of the issuer's common stock." The triggering event date for this amendment is listed as September 30, 2026. The filing checks the box for ownership of 5 percent or less of a class under Item 5, consistent with the reported 0% holding.
The filing notes that TCM serves as investment manager and general partner of the Fund, and that Collin McBirney, as member-manager of TCM, could under Rule 13d-3 be deemed to share power over the Fund's securities. However, the filing expressly states that neither the filing nor its contents constitutes an admission of beneficial ownership by TCM or Mr. McBirney for any other purpose, and that each disclaims beneficial ownership except to the extent of their respective pecuniary interests.
What Was Disclosed
Topline Capital Management, Topline Capital Partners, and Collin McBirney filed a Schedule 13G amendment reporting zero shares beneficially owned in Nutex Health Inc. as of September 30, 2026, with confirmation that no shares were held as of November 13, 2026.



Please wait processing your request...